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A sensitive and specific radioimmunoassay suitable for direct measurement of leukotriene Cd was 
developed. Acetylated leukotriene CA was coupled to polyamino bovine serum albumin using 
I-ethyl-3-(3-dimethylamino-propyl) carbodiimide hydrochloride as coupling agent. The conjugate in 
complete or incomplete Freund’s adjutant was injected into New Zealand white rabbits. At a final 
antiplasma dilution of 1: 1050 the lowest detection limit of leukotriene Cd was 0.046 pmol. The antiplasma 
cross-reacted < 1% with leukotrienes Dd, E4 and F4, while high relative cross-reaction (86-100%) was 
obtained with leukotrienes C3, C5 and 11-trans leukotriene C4. In experiments where known amounts of 
leukotriene Cd were added to leukocyte suspensions, 67-1005’0 of the added amount was recovered by the 
method. The radioimmunoassay was used to study leukotriene C4 formation after stimulation of leukocyte 
suspensions with the ionophore A23187. 
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1. INTRODUCTION 
Leukotriene (LT)Cd [1,2], a glutathione-con- 
taining derivative of arachidonic acid, constricts 
pulmonary airways and increases vascular perme- 
ability in the microcirculation with a potency, 
orders of magnitude greater than that of histamine 
[3,4]. LTG is formed by enzymatic addition of 
glutathione to an epoxide derivative of arachidonic 
acid, LTA4 [5,6], and is metabolized by stepwise 
elimination of glutamic acid and glycine through 
transpeptidation and/or hydrolytic reactions [7,8], 
The leukotrienes D4 and E4 generated by the latter 
reactions have approximately the same biological 
potency as LTC4 on lung strips [9] and on vascular 
permeability [4], in some species. LTE4 is meta- 
bolized to LTF4 [lo] and other polar products, 
which are excreted in the urine and in the bile 
[11,12]. Leukotrienes Cd, D4 and E4 are the bio- 
logically active components of slow-reacting sub- 
stance of anaphylaxis [ 131, which mediate allergic 
reactions [ 141. 
mation, the availability of sensitive and specific 
assay methods is of great importance. HPLC-chro- 
matography combined with UV-spectroscopy has 
been used for quantitative determinations of leuko- 
trienes. A drawback of this method is, however, 
the low sensitivity. A more sensitive but less specific 
method is bioassay. None of these methods is suit- 
able for large numbers of samples ince careful and 
time-consuming purification of each sample is 
necessary. Recently, radioimmunoassays for LTB4 
[15] and LTG [ 161 have been reported. In addition 
a radioimmunoassay of the leukotrienes of slow 
reacting substance of anaphylaxis has been de- 
veloped [ 171. The present report describes a radio- 
immunoassay for LTG which is superior to the 
previous methods both with regard to sensitivity 
and specificity. 
2. MATERIALS AND METHODS 
2.1. Antiplasma 
For more detailed studies of the physiological 
roles of leukotrienes in, e.g., allergy and inflam- 
The immunogen was prepared by coupling ace- 
tylated LTC4 to polyamino-bovine serum albumin 
(PABSA). For the acetylation, 100,ug of LTC4 in 
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0.3 ml of pyridine was incubated with 10~1 of 
acetic anhydride for 15 min at 22°C under an 
atmosphere of argon. The solvent was removed by 
evaporation with a stream of nitrogen and the 
acetylated LTC4 was redissolved in 100 ~1 meth- 
anol-water (1: 1, v/v). PABSA was prepared by 
reacting 100 mg recrystallized BSA with 30 mg of 
recrystallized triethylene tetramine-HCl and 40 mg 
of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) in 10 ml water adjusted to 
pH 4.0 with 1 M HCl for 16 h at 22”C, and was 
dialyzed against distilled water for 48 h at 4°C and 
lyophilized. Acetylated LTC4 (100 pg) was incu- 
bated with 2.5 mg PABSA and 10 mg EDC in 
0.3 ml distilled water (pH 4.0) for 60 min at 22°C 
and 180 min at 4°C under argon. Thereafter the 
conjugate obtained was dialyzed under nitrogen 
and used immediately for immunization. New 
Zealand white rabbits (4 kg) received 0.4 mg of 
conjugate in complete Freund’s adjuvant in mul- 
tiple subcutaneous and intradermal sites initially 
and 0.2 mg conjugate in incomplete Freund’s adju- 
vant at 4, 8 and 12 weeks, and were bled at 16, 20 
and 24 weeks. Before use the antiplasma was 
diluted 1 : 150 or 1: 300 (v/v) with 0.05 M Tris-HCl 
(pH 8.0). 
2.2. Tritium-labelled leukotriene Cd 
[ 3Hs] LTC4 (10 Ci/mmol), prepared from [ 3Hs]- 
arachidonic acid using the methods described for 
thesynthesisof [3H6]LTC3 [18], or [14,15-3Hz]LTC4 
(34 Ci/mmol, New England Nuclear, Boston MA) 
were used as tracers. 
2.3. Unlabelled leukotrienes and related 
compounds 
LTC3 [18], LTC4 [1,2], 11-trans LTC4 [19], 
LTCs [20], LTD4 [7], LTE4 [8] and LTR [lo] were 
prepared as described. 5S,12S-DHETE, LTB4, 
6-tram LTB4 and 6-trans, 12-epi LTB4 were pre- 
pared as in [21] and 20-OH LTB4 and 20-COOH 
LTB4 as in [22] and [23], respectively. SS-HETE 
and 12S-HETE were prepared as in [24]. Arachi- 
donic acid was from Nu-Check Prep. (Elysian MN) 
and PGA2, PGB2 and PGE2 from The Upjohn 
Company (Kalamazoo MI). 
2.4. Cell preparations and incubations 
Human PMN leukocyte suspensions - 60 x lo6 
cells/ml of phosphate-buffered saline containing 
84 
0.87 mM CaC12 (pH 7.4) - were prepared as in 
[25]. One-ml aliquots of PMN leukocyte suspen- 
sions were preincubated at 37°C for 1 min prior to 
incubation with various concentrations (O-2 PM) 
of ionophore A23187 (Calbiochem, La Jolla CA) 
for 5 min or with 0.38 FM A23187 for various in- 
cubation times. The incubations were stopped by 
addition of 1 ml ice-cold 0.05 M Tris-HCl 
(pH 8.0) followed by rapid freezing of the samples 
at -7O’C. After thawing the samples were cen- 
trifuged at 1400 x g in order to remove the cells 
prior to radioimmunoassay. All samples were 
assayed directly without further purification. 
2.5. Radioimmunoassay 
To a series of test tubes were added 0.2 ml 
0.05 M Tris-HCl (pH 8.0) followed by addition in 
triplicate of 0.1 ml of standard compounds (LTC4: 
O-5.86 pmoV0.1 ml; compounds tested for cross- 
reaction O-3000 pmoV0.1 ml) or unknown 
samples. Thereafter 0.1 ml of antiplasma and 
0.1 ml of radio-labelled ligand (8000 dpm) were 
added. Depending on the radioligand used 
([3Hs]LTC4; 10 Ci/mmol or [14,15-3H2]LTC4; 34 
Ci/mmol) the antiplasma was diluted 1: 150 (v/v) 
or 1 : 300 (v/v), respectively. For determination of 
total radioactivity added, 3 tubes received 0.1 ml 
of Tris-HCl instead of antiplasma. After addition 
of 0.2 ml of bovine gammaglobulin (5 mg/ml; 
Sigma) the mixtures were incubated at room 
temperature for 60 min. Thereafter the tubes were 
left at 0°C for 15 min prior to addition of 0.7 ml 
of ice-cold 25% (v/v) aqueous polyethylene glycol 
4000 (Kebo AB, Stockholm) [26]. The contents 
were vigorously mixed and then centrifuged at 
1400 x g for 60 min at 4°C. One-ml aliquots of the 
supernatants were mixed with 0.5 ml Hz0 and 
10 ml Instagel (Packard Instrument, Stockholm) 
in scintillation vials and the radioactivity was 
determined in a liquid scintillation spectrometer. 
Calculations were performed using off-line com- 
puterization [27]. All dilutions were made in 
0.05 M Tris-HCl (pH 8.0). 
3. RESULTS 
An antiplasma against LTC4 was obtained by 
immunizing rabbits with a conjugate of acetylated 
LTC4 on polyamino-bovine serum albumin. At a 
final dilution of 1: 1050, the antiplasma bound 
50% of the radioactivity added. Ten percent dis- 
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Fig.1. Standard curve for LTC4. [3Hs]LTC4 (10 Ci/ 
mmol) was used as tracer. Antiplasma dilution was 
1: 150 (v/v). Radioimmunoassay was carried out as 
described in the text. 
Table 1 
Specificity of LTC4 antiplasma 
Compound Picomoles required Relative 
to displace 50% cross-reaction 
of bound (Vo) 
radioactivity 
LTC‘, 
11 -Irans LTC4 
LTC5 
LTC3 
LTR 
LTD4 
LTB 
LTB4 
20-OH LTB4 
20-COOH LTB4 
6-tram LTB4 
6-tram, 1Zepi LTB4 
SS, 12.SDHETE 
SS-HETE 
12S-HETE 
PGAz 
PGB2 
PGEz 
Arachidonic acid 
Glutathione 
Glutathione disulfide 
Glutathione-S- 
paracetamol 
0.30 100 
0.30 100 
0.33 90.9 
0.35 85.7 
64 0.47 
380 0.08 
410 0.07 
>3000 >O.Ol 
>3000 >O.Ol 
>3000 >O.Ol 
>3000 >O.Ol 
>3000 >O.Ol 
> 3000 >O.Ol 
> 3000 > 0.01 
>3000 >O.Ol 
> 3000 >O.Ol 
>3000 >O.Ol 
>3000 >O.Ol 
>3000 > 0.01 
> 3000 >O.Ol 
> 3000 >O.Ol 
>3000 >O.Ol 
13Hs]LTC4 (10 Ci/mmol) was used as tracer. Antiplasma 
dilution was 1: 150 (v/v). Radioimmunoassay was car- 
ried out as described in the text. 
placement of bound activity was obtained after 
addition of 0.046 pmol (28 pg) LTG while 50 and 
90% displacement was achieved by 0.30 and 
1.2 pmol, respectively. A typical standard curve is 
shown in fig. 1. 
Results of studies of the specificity of anti-LTG 
binding showed that the relative cross-reaction of 
LTD4, LTE4 and LTS was < 1% for each com- 
pound, while 1 I-trans LTG, LTC3 and LTCs 
cross-reacted 100, 86 and 91070, respectively (table 
1). Other compounds tested, including LTB4 and 
5,12-di-HETEs, mono-HETEs, arachidonic acid, 
prostaglandins, glutathione and glutathione disul- 
fide cross-reacted <O.Ol%. 
To test the validity of the radioimmunoassay, 
known amounts of LTG (O-100 pmol/ml) were 
added to l-ml aliquots of human PMN leukocyte 
suspensions. After mixing, the samples were diluted 
with 1 ml of ice-cold Tris-HCl and rapidly frozen at 
-70°C. After thawing and centrifugation, the sam- 
ples were analyzed by radioimmunoassay. There 
was a good correlation between added amounts of 
LTG and the results obtained with the RIA (table 
2). A background level of 1.1 pmol LTCJml cell 
suspension was detected. After correction for the 
Table 2 
Radioimmunoassay of known amounts of LTC4 added 
to leukocyte suspensions 
LTC4 added; LTCh measured; 
pmol/ml cell pmol/ml cell 
suspension suspension 
0 1.1 
0.5 1.6 
1.0 2.0 
5.0 4.3 
10.0 7.4 
50.0 46.1 
100.0 74.8 
Recovery 
(%) 
100.0 
95.2 
70.5 
66.7 
90.2 
74.0 
Various amounts of LTC4 were added in 10 ~1 EtOH to 
1 ml PMN leukocyte suspensions. The samples were 
immediately mixed with 1 ml ice-cold Tris-HCl and 
rapidly frozen at -70°C. Radioimmunoassay was car- 
ried out as described in the text. Each value is the mean 
of 3 determinations on each of two samples. Recovery is 
determined as: 
amount LTCS measured 
amount LTC4 added + background LTC4 
x 100 
85 
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Fig.2. Dose-response curve for LTC4 production by 
PMNL suspensions after addition of ionophore A23 187 
in various concentrations. The samples were incubated 
for 5 min at 37°C. Each point is the mean value of tripli- 
cate determinations on each of two samples. Radioim- 
munoassay was carried out as described in the text. 
Time (min) 
Fig.3. Time-course of LTC4 production by PMNL sus- 
pensions after stimulation with 0.38 ,uM ionophore 
A23187 at 37°C. Each point is the mean value of tripli- 
cate determinations on each of two samples. Radioim- 
munoassay was carried out as described in the text. 
background the recovery was 67-100% of added 
amounts. 
The biosynthesis of LTC4 by human PMN leuko- 
cyte suspensions stimulated with ionophore A23 187 
was determined by the radioimmunoassay. As 
shown in fig.2, 0.2 yM ionophore increased the 
levels of LTG from a background level of 
0.8 pmol/ml to 13.4 pmol/ml. Thereafter the con- 
centrations of LTG increased with increasing 
concentrations of ionophore A23 187 reaching 
286 pmol/ml at 2 PM of the ionophore. Fig.3 
shows the time-course of LTG production after 
stimulation of the PMN leukocytes with 0.38 PM 
ionophore A23187. After 45 s, elevated levels were 
detected and thereafter the concentrations of LTC4 
increased linearly and reached a plateau after 
about 5 min. 
4. DISCUSSION 
We describe here the development of a sensitive 
and specific radioimmunoassay for LTC4. The 
antibodies were obtained from rabbits which had 
been immunized with a conjugate of acetylated 
LTG on polyamino-bovine serum albumin. This 
conjugate was not further characterized and con- 
ceivably the 3 carboxyl groups may have given rise 
to 3 different conjugates. 
The LTG-antiplasma obtained possessed a rela- 
tively high degree of sensitivity with a lowest detec- 
tion limit for LTC4 of 0.046 pmol(28 pg) at a final 
antiplasma dilution of 1: 1050 with [3Hs]LTCq 
(10 Ci/mmol; 8000 dpm) as tracer. When a LTG- 
tracer with higher spec. act. (34 Ci/mmol) was 
used, the lowest detection limit was decreased to 
0.023 pmol (14 pg, not shown). 
Specificity studies of the antiplasma revealed very 
high cross-reactivities of l l-0-ans LTG, LTCS and 
LTC3. This indicates that the double bonds at C-l 1, 
C-14 and C-17 are weak immunodeterminants. On 
the other hand the antibodies specifically recog- 
nized changes within the 6-sulfidopeptide. Thus, 
LTD4, LTE4 and LTF4 cross-reacted 0.07,0.08 and 
0.47%, respectively. Theoretically, these values 
could be explained by rapid destruction of the 
sulfidopeptide moiety during radioimmunoassay 
incubation. However, considerably higher cross- 
reactions for LTD4 and LTE4 under similar condi- 
tions have been reported [16,17], suggesting that 
the antibodies used in this study more specifically 
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recognize this part of the molecule. However, the 
sulfidopeptide alone does not cause immuno- 
recognition since no significant cross-reaction was 
observed with glutathione-S-paracetamol. Because 
of the total cross-reactivity of the antiplasma, with 
11 -tram LTC4, the radioimmunoassay will 
measure the sum of this compound and LTG. 
However, in comparison to the levels of LTG only 
small amounts of 1 l-tram LTC4 were found after 
stimulation of human PMN leukocytes with 
ionophore A23 187 [28]. 
Because of the relatively high physiological con- 
centration of glutathione disulfide in plasma and 
glutathione in certain tissues, it was important to 
determine the cross-reaction with anti-LTG of 
these compounds at high concentrations. How- 
ever, even at 1.5 mM, glutathione or glutathione 
disulfide failed to significantly displace bound 
tracer from the antiplasma. This shows that high 
concentrations of the compounds in samples will 
not interfere with the analyses of LTC4. 
After addition of known amounts of LTC4 to 
PMN leukocyte suspensions around 100% was 
radioimmunologically recovered in samples con- 
taining low amounts (~2 pmol/ml) of the leuko- 
triene. At higher concentrations (addition of 
5-100 pmol LTCd/ml) 67-90% was recovered by 
the method. The reason for the decrease in re- 
covery is not known. 
Determinations of LTC4 production in PMN 
leukocyte suspensions after stimulation with iono- 
phore A23187 show that the method can be used to 
measure LTG formation from endogenous pre- 
cursors by these cells. The amounts of LTC4 re- 
ported here are of the same order of magnitude as 
those reported for human or horse PMNs after 
ionophore A23 187 stimulation [16,29]. However, 
more physiological stimuli may give rise to lower 
levels of the leukotrienes. Thus, the amounts of 
LTB4 produced after stimulation of PMN leuko- 
cyte suspensions with serum-coated zymosan were 
calculated to be lo-50-times lower than those pro- 
duced by the same cell suspensions after stimula- 
tion with arachidonic acid plus ionophore A23187 
[25]. A similar decrease of LTC4 values, would 
however not prevent measurements by the present 
method. The radioimmunoassay described here 
seems suitable for direct determination of minute 
amounts of LTC4 in small volume samples of 
various origin. 
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